Prelude Therapeutics, Inc. (PRLD)

4.52 -0.18 (-3.83%) USD  |  NASDAQ  |  Apr 27, 15:29
More

Prelude Therapeutics EPS Diluted (Quarterly YoY Growth)

EPS Diluted (Quarterly YoY Growth) Chart

View EPS Diluted (Quarterly YoY Growth) for PRLD.
Upgrade now.
Sep '18
Jan '19
May '19
 
285.00
270.00
255.00
240.00
View EPS Diluted (Quarterly YoY Growth) Chart
Start Trial

Historical Data

View Historical Data
Start Trial

EPS Diluted (Quarterly YoY Growth) Range, Past 5 Years

View EPS Diluted (Quarterly YoY Growth) Range, Past 5 Years
Start Trial
--
Minimum
--
Maximum
--
Average
--
Median

EPS Diluted (Quarterly YoY Growth) Benchmarks

View EPS Diluted (Quarterly YoY Growth) Benchmarks
Start Trial
Incyte Corp. Upgrade
Niagen Bioscience, Inc. Upgrade
Immunome, Inc. Upgrade
Sana Biotechnology, Inc. Upgrade
Moderna, Inc. Upgrade